[Federal Register Volume 80, Number 108 (Friday, June 5, 2015)]
[Notices]
[Page 32136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13697]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1069]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Blood Establishment Registration and 
Product Listing, Form FDA 2830

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled, ``Blood Establishment Registration 
and Product Listing, Form FDA 2830'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, [email protected].

SUPPLEMENTARY INFORMATION: On February 09, 2015, the Agency submitted a 
proposed collection of information entitled, ``Blood Establishment 
Registration and Product Listing, Form FDA 2830'' to OMB for review and 
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, 
and a person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number. OMB has now 
approved the information collection and has assigned OMB control number 
0910-0052. The approval expires on May 31, 2018. A copy of the 
supporting statement for this information collection is available on 
the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: June 1, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-13697 Filed 6-4-15; 8:45 am]
BILLING CODE 4164-01-P